Details for New Drug Application (NDA): 021267
✉ Email this page to a colleague
The generic ingredient in VFEND is voriconazole. There are fourteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the voriconazole profile page.
Summary for 021267
Tradename: | VFEND |
Applicant: | Pf Prism Cv |
Ingredient: | voriconazole |
Patents: | 0 |
Suppliers and Packaging for NDA: 021267
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VFEND | voriconazole | INJECTABLE;INTRAVENOUS | 021267 | NDA | Roerig | 0049-3190 | 0049-3190-01 | 1 VIAL, SINGLE-USE in 1 CARTON (0049-3190-01) / 20 mL in 1 VIAL, SINGLE-USE |
VFEND | voriconazole | INJECTABLE;INTRAVENOUS | 021267 | NDA | Roerig | 0049-3190 | 0049-3190-28 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0049-3190-28) / 20 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 200MG/VIAL | ||||
Approval Date: | May 24, 2002 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 021267
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pf Prism Cv | VFEND | voriconazole | INJECTABLE;INTRAVENOUS | 021267-001 | May 24, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Pf Prism Cv | VFEND | voriconazole | INJECTABLE;INTRAVENOUS | 021267-001 | May 24, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Pf Prism Cv | VFEND | voriconazole | INJECTABLE;INTRAVENOUS | 021267-001 | May 24, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Pf Prism Cv | VFEND | voriconazole | INJECTABLE;INTRAVENOUS | 021267-001 | May 24, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Pf Prism Cv | VFEND | voriconazole | INJECTABLE;INTRAVENOUS | 021267-001 | May 24, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Pf Prism Cv | VFEND | voriconazole | INJECTABLE;INTRAVENOUS | 021267-001 | May 24, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription